These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 19916710)
1. A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study. Chaiworapongsa T; Romero R; Tarca A; Kusanovic JP; Mittal P; Kim SK; Gotsch F; Erez O; Vaisbuch E; Mazaki-Tovi S; Pacora P; Ogge G; Dong Z; Kim CJ; Yeo L; Hassan SS J Matern Fetal Neonatal Med; 2009 Dec; 22(12):1122-39. PubMed ID: 19916710 [TBL] [Abstract][Full Text] [Related]
2. An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study. Romero R; Chaiworapongsa T; Erez O; Tarca AL; Gervasi MT; Kusanovic JP; Mittal P; Ogge G; Vaisbuch E; Mazaki-Tovi S; Dong Z; Kim SK; Yeo L; Hassan SS J Matern Fetal Neonatal Med; 2010 Dec; 23(12):1384-99. PubMed ID: 20459337 [TBL] [Abstract][Full Text] [Related]
3. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241 [TBL] [Abstract][Full Text] [Related]
4. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia. Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962 [TBL] [Abstract][Full Text] [Related]
6. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. Erez O; Romero R; Espinoza J; Fu W; Todem D; Kusanovic JP; Gotsch F; Edwin S; Nien JK; Chaiworapongsa T; Mittal P; Mazaki-Tovi S; Than NG; Gomez R; Hassan SS J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652 [TBL] [Abstract][Full Text] [Related]
7. Plasma protein Z concentrations in pregnant women with idiopathic intrauterine bleeding and in women with spontaneous preterm labor. Kusanovic JP; Espinoza J; Romero R; Hoppensteadt D; Nien JK; Kim CJ; Erez O; Soto E; Fareed J; Edwin S; Chaiwerapongsa T; Than NG; Yoon BH; Gomez R; Papp Z; Hassan SS J Matern Fetal Neonatal Med; 2007 Jun; 20(6):453-63. PubMed ID: 17674255 [TBL] [Abstract][Full Text] [Related]
8. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. Adekola H; Romero R; Chaemsaithong P; Korzeniewski SJ; Dong Z; Yeo L; Hassan SS; Chaiworapongsa T J Matern Fetal Neonatal Med; 2015; 28(14):1621-32. PubMed ID: 25211383 [TBL] [Abstract][Full Text] [Related]
9. Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. Chaiworapongsa T; Romero R; Savasan ZA; Kusanovic JP; Ogge G; Soto E; Dong Z; Tarca A; Gaurav B; Hassan SS J Matern Fetal Neonatal Med; 2011 Oct; 24(10):1187-207. PubMed ID: 21827221 [TBL] [Abstract][Full Text] [Related]
10. Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma. Chaiworapongsa T; Romero R; Gotsch F; Kusanovic JP; Mittal P; Kim SK; Erez O; Vaisbuch E; Mazaki-Tovi S; Kim CJ; Dong Z; Yeo L; Hassan SS J Matern Fetal Neonatal Med; 2010 Feb; 23(2):167-78. PubMed ID: 20213923 [TBL] [Abstract][Full Text] [Related]
11. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. Kusanovic JP; Romero R; Chaiworapongsa T; Erez O; Mittal P; Vaisbuch E; Mazaki-Tovi S; Gotsch F; Edwin SS; Gomez R; Yeo L; Conde-Agudelo A; Hassan SS J Matern Fetal Neonatal Med; 2009 Nov; 22(11):1021-38. PubMed ID: 19900040 [TBL] [Abstract][Full Text] [Related]
12. Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death. Whitten AE; Romero R; Korzeniewski SJ; Tarca AL; Schwartz AG; Yeo L; Dong Z; Hassan SS; Chaiworapongsa T Am J Obstet Gynecol; 2013 Apr; 208(4):310.e1-310.e11. PubMed ID: 23333548 [TBL] [Abstract][Full Text] [Related]
13. Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Chaiworapongsa T; Romero R; Korzeniewski SJ; Kusanovic JP; Soto E; Lam J; Dong Z; Than NG; Yeo L; Hernandez-Andrade E; Conde-Agudelo A; Hassan SS Am J Obstet Gynecol; 2013 Apr; 208(4):287.e1-287.e15. PubMed ID: 23333542 [TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. Chaiworapongsa T; Romero R; Korzeniewski SJ; Cortez JM; Pappas A; Tarca AL; Chaemsaithong P; Dong Z; Yeo L; Hassan SS J Matern Fetal Neonatal Med; 2014 Jan; 27(2):132-44. PubMed ID: 23687930 [TBL] [Abstract][Full Text] [Related]
15. Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study. Korzeniewski SJ; Romero R; Chaiworapongsa T; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L Am J Obstet Gynecol; 2016 May; 214(5):629.e1-629.e17. PubMed ID: 26688491 [TBL] [Abstract][Full Text] [Related]
16. High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor. Erez O; Romero R; Vaisbuch E; Kusanovic JP; Mazaki-Tovi S; Chaiworapongsa T; Gotsch F; Fareed J; Hoppensteadt D; Than NG; Yoon BH; Edwin S; Dong Z; Espinoza J; Mazor M; Hassan SS J Matern Fetal Neonatal Med; 2010 Jan; 23(1):23-33. PubMed ID: 19883261 [TBL] [Abstract][Full Text] [Related]
17. Unexplained fetal death is associated with increased concentrations of anti-angiogenic factors in amniotic fluid. Chaiworapongsa T; Romero R; Kusanovic JP; Savasan ZA; Kim SK; Mazaki-Tovi S; Vaisbuch E; Ogge G; Madan I; Dong Z; Yeo L; Mittal P; Hassan SS J Matern Fetal Neonatal Med; 2010 Aug; 23(8):794-805. PubMed ID: 20199197 [TBL] [Abstract][Full Text] [Related]
18. Pentraxin 3 in maternal circulation: an association with preterm labor and preterm PROM, but not with intra-amniotic infection/inflammation. Cruciani L; Romero R; Vaisbuch E; Kusanovic JP; Chaiworapongsa T; Mazaki-Tovi S; Dong Z; Kim SK; Ogge G; Yeo L; Mittal P; Hassan SS J Matern Fetal Neonatal Med; 2010 Oct; 23(10):1097-105. PubMed ID: 20121391 [TBL] [Abstract][Full Text] [Related]
19. Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes. Savasan ZA; Romero R; Chaiworapongsa T; Kusanovic JP; Kim SK; Mazaki-Tovi S; Vaisbuch E; Mittal P; Ogge G; Madan I; Dong Z; Yeo L; Hassan SS J Matern Fetal Neonatal Med; 2010 Aug; 23(8):828-41. PubMed ID: 20158393 [TBL] [Abstract][Full Text] [Related]
20. Circulating angiogenic factors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome and selective intrauterine growth restriction. Yinon Y; Ben Meir E; Berezowsky A; Weisz B; Schiff E; Mazaki-Tovi S; Lipitz S Am J Obstet Gynecol; 2014 Feb; 210(2):141.e1-7. PubMed ID: 24055584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]